ArticleGlobal medical genetics2021

Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M.

Xiaoying ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.